Organization

Biosergen

1 clinical trial

Clinical trial

A Phase 1, Double-blinded, Placebo-controlled Study to Assess the Safety, Tolerability, and Pharmacokinetics of BSG005 Following Single and Multiple Ascending Doses in Healthy Subjects

Status: Recruiting, Estimated PCD: 2023-03-01